{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:19:13Z","timestamp":1783055953405,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K00368"],"award-info":[{"award-number":["25K00368"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K15312"],"award-info":[{"award-number":["24K15312"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbrc.2026.153836","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:29:50Z","timestamp":1777271390000},"page":"153836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antiproliferative effects of TUBB3 in ER\u03b1-positive postmenopausal breast cancer model cells"],"prefix":"10.1016","volume":"821","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5626-1950","authenticated-orcid":false,"given":"Masayo","family":"Hirao-Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Kanameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2193-1421","authenticated-orcid":false,"given":"Shuso","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153836_bib1","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2016.67.1487","article-title":"Endocrine therapy for hormone receptor-positive metastatic breast cancer: american society of clinical oncology guideline","volume":"34","author":"Rugo","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.153836_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Early breast cancer Trialists' Collaborative Group (EBCTCG) Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.153836_bib3","first-page":"4355","article-title":"Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens","volume":"47","author":"Katzenellenbogen","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153836_bib4","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1210\/endo.139.10.6229","article-title":"Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells","volume":"139","author":"Jeng","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2026.153836_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-0760(02)00074-2","article-title":"Molecular changes associated with the acquisition of estrogen hypersensitivity in MCF-7 breast cancer cells on long-term estrogen deprivation","volume":"81","author":"Chan","year":"2002","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bbrc.2026.153836_bib6","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.21873\/anticanres.11087","article-title":"Bongkrekic acid as a Warburg effect modulator in long-term estradiol-deprived MCF-7 breast cancer cells","volume":"36","author":"Takeda","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2026.153836_bib7","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41467-017-01864-y","article-title":"Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance","volume":"8","author":"Martin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153836_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2019.10.018","article-title":"Metalloestrogenic effects of cadmium are absent in long-term estrogen-deprived MCF-7 cells: evidence for the involvement of constitutively activated estrogen receptor \u03b1 and very low expression of G protein-coupled estrogen receptor 1","volume":"319","author":"Hirao-Suzuki","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbrc.2026.153836_bib9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/jnci\/51.5.1409","article-title":"A human cell line from a pleural effusion derived from a breast carcinoma","volume":"51","author":"Soule","year":"1973","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbrc.2026.153836_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxlet.2023.02.008","article-title":"Repeated exposure to 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) accelerates ligand-independent activation of estrogen receptors in long-term estradiol-deprived MCF-7 cells","volume":"378","author":"Hirao-Suzuki","year":"2023","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbrc.2026.153836_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jb\/mvae074","article-title":"Long-term estrogen-deprived estrogen receptor \u03b1-positive breast cancer cell migration assisted by fatty acid 2-hydroxylase","volume":"177","author":"Kanameda","year":"2025","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbrc.2026.153836_bib12","first-page":"63","article-title":"Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention","volume":"1766","author":"Cavalieri","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2026.153836_bib13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.lfs.2004.02.023","article-title":"Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol?","volume":"75","author":"Mueck","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2026.153836_bib14","first-page":"2269","article-title":"Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?","volume":"58","author":"Zhu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153836_bib15","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.3390\/cimb45090464","article-title":"2-Methoxyestradiol as an antiproliferative agent for long-term estrogen-deprived breast cancer cells","volume":"45","author":"Hirao-Suzuki","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153836_bib16","doi-asserted-by":"crossref","first-page":"T233","DOI":"10.1530\/JME-18-0045","article-title":"Sulfation PATHWAYS: steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects","volume":"61","author":"Potter","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.153836_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.153836_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/cancers10080274","article-title":"Genetics and expression profile of the tubulin gene superfamily in breast cancer subtypes and its relation to taxane resistance","volume":"10","author":"Nami","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2026.153836_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.20517\/cdr.2022.96","article-title":"Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance","volume":"6","author":"Scherbakov","year":"2023","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.bbrc.2026.153836_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117360","article-title":"Interactions between cadmium and 17\u03b2-estradiol at physiologically relevant levels evoke unsynchronized events in MCF-7 breast cancer cells: impaired cell growth and activation of estrogen receptor \u03b1-related pathways","volume":"500","author":"Kanameda","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153836_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2131\/jts.47.159","article-title":"Perfluorooctanoic acid (PFOA) as a stimulator of estrogen receptor-negative breast cancer MDA-MB-231 cell aggressiveness: evidence for involvement of fatty acid 2-hydroxylase (FA2H) in the stimulated cell migration","volume":"47","author":"Sakai","year":"2022","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.bbrc.2026.153836_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2020.07.043","article-title":"Fatty acid 2-hydroxylase (FA2H) as a stimulatory molecule responsible for breast cancer cell migration","volume":"531","author":"Hirao-Suzuki","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153836_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/bjc.2012.553","article-title":"Altered TUBB3 expression contributes to the epothilone response of mitotic cells","volume":"108","author":"Narvi","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.153836_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/cm.20377","article-title":"\u03b23-Tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway","volume":"66","author":"Saussede-Aim","year":"2009","journal-title":"Cell Motil. Cytoskelet."},{"key":"10.1016\/j.bbrc.2026.153836_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jphs.2022.09.006","article-title":"Stathmin expression alters the antiproliferative effect of eribulin in leiomyosarcoma cells","volume":"150","author":"Azumi","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2026.153836_bib26","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1007\/s13277-014-2101-z","article-title":"Association of ABCB1, \u03b2 tubulin I, and III with multidrug resistance of MCF7\/DOC subline from breast cancer cell line MCF7","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bbrc.2026.153836_bib27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"Gy\u00f6rffy","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2026.153836_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1677\/erc.1.01257","article-title":"Endocrine therapy resistance can be associated with high estrogen receptor \u03b1 (ER\u03b1) expression and reduced ER\u03b1 phosphorylation in breast cancer models","volume":"13","author":"Kuske","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbrc.2026.153836_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.cell.2019.06.026","article-title":"Therapeutic ligands antagonize estrogen receptor function by impairing its mobility","volume":"178","author":"Guan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153836_bib30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1634\/theoncologist.12-7-774","article-title":"Fulvestrant (Faslodex\u00ae) - how to make a good drug better","volume":"12","author":"Robertson","year":"2007","journal-title":"Oncologist"},{"issue":"Suppl 7","key":"10.1016\/j.bbrc.2026.153836_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12864-016-2911-z","article-title":"Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer","volume":"17","author":"Jiang","year":"2016","journal-title":"BMC Genom."},{"key":"10.1016\/j.bbrc.2026.153836_bib32","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/jnci\/93.22.1714","article-title":"Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17\u03b2-estradiol","volume":"93","author":"Song","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbrc.2026.153836_bib33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/bmj.2.4368.393","article-title":"Influence of synthetic oestrogens on advanced malignant disease","volume":"2","author":"Haddow","year":"1944","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbrc.2026.153836_bib34","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-23-0488","article-title":"Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer","volume":"29","author":"Traphagen","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153836_bib35","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/cancers15143647","article-title":"Revisiting estrogen for the treatment of endocrine-resistant breast cancer: novel therapeutic approaches","volume":"15","author":"Shete","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2026.153836_bib36","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/jid.2008.406","article-title":"Loss of class III \u03b2-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells","volume":"129","author":"Akasaka","year":"2009","journal-title":"J. Invest. Dermatol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:44:23Z","timestamp":1783053863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26006005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"alternative-id":["S0006291X26006005"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153836","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiproliferative effects of TUBB3 in ER\u03b1-positive postmenopausal breast cancer model cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153836"}}